light stimulation Search Results


90
Roithner Lasertechnik red light stimulation
Red Light Stimulation, supplied by Roithner Lasertechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/red light stimulation/product/Roithner Lasertechnik
Average 90 stars, based on 1 article reviews
red light stimulation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoolLED Inc pe2 light stimulator
Pe2 Light Stimulator, supplied by CoolLED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe2 light stimulator/product/CoolLED Inc
Average 90 stars, based on 1 article reviews
pe2 light stimulator - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Axion BioSystems multi-well light stimulation system lumos 24
Multi Well Light Stimulation System Lumos 24, supplied by Axion BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-well light stimulation system lumos 24/product/Axion BioSystems
Average 90 stars, based on 1 article reviews
multi-well light stimulation system lumos 24 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoolLED Inc 2p stimulation light path
2p Stimulation Light Path, supplied by CoolLED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2p stimulation light path/product/CoolLED Inc
Average 90 stars, based on 1 article reviews
2p stimulation light path - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Diagnosys LLC light guide electrodes that function simultaneously as a stimulator and an electrode
Light Guide Electrodes That Function Simultaneously As A Stimulator And An Electrode, supplied by Diagnosys LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/light guide electrodes that function simultaneously as a stimulator and an electrode/product/Diagnosys LLC
Average 90 stars, based on 1 article reviews
light guide electrodes that function simultaneously as a stimulator and an electrode - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
NEWDOON Inc blue light laser stimulation
Blue Light Laser Stimulation, supplied by NEWDOON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blue light laser stimulation/product/NEWDOON Inc
Average 90 stars, based on 1 article reviews
blue light laser stimulation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Cyro Industries polymer that glows when stimulated by two different infrared light sources
Polymer That Glows When Stimulated By Two Different Infrared Light Sources, supplied by Cyro Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polymer that glows when stimulated by two different infrared light sources/product/Cyro Industries
Average 90 stars, based on 1 article reviews
polymer that glows when stimulated by two different infrared light sources - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoolLED Inc blue light stimulation
Blue Light Stimulation, supplied by CoolLED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blue light stimulation/product/CoolLED Inc
Average 90 stars, based on 1 article reviews
blue light stimulation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
NEWDOON Inc constant illumination of yellow light stimulation
BLA to vHip projections regulate anxiety-like behavior in morphine-withdrawn mice. (A–E) Chemogenetic experiment. (A) Workflow for the chemogenetic experiment. (B) Schematic (left) and representative image (right) of chemogenetic virus injection. Scale bar: 200 μm. (C) The Mor-A×CNO mice exhibited significantly increased central time and central distances in the OFT. (D) The Mor-A × CNO mice exhibited significantly increased open-arm times and entries in the EPM. (E) The hM4Di inhibition accelerated the decreased rate of morphine-paired preference in the Mor-A mice. (F–H) Optogenetic experiment. (F) Schematic of the virus injection site in the BLA and optical fiber implantation site in the vHip. (Right) Image of a coronal brain slice showing the expression of eNpHR-mCherry in the BLA. Scale bar: 200 μm. (G) Increased open-arm entries and time spent during the light-on epoch. (H) Increased time spent and distances traveled in the central area of the OFT during the eNpHR <t>illumination</t> epoch. The EPM (I) and OFT (J) tests of the saline + eNpHR group and the saline + mCherry group. Data are expressed as the mean ± SEM. In the chemogenetic experiment, morphine CNO-treated mice were compared with morphine DMSO-treated mice. In the CPP results, *: comparison between the extinction group and the post-test group, #: comparison between the 2 indicated groups. In the optogenetic results, #: comparison between the Mor+mcherry and the Mor+eNPHR group during the light on epoch. n = 8–10/group.* P < 0.05, ** P < 0.01, *** P < 0.001, # P < 0.05, ## P < 0.01, #### P < 0.0001.
Constant Illumination Of Yellow Light Stimulation, supplied by NEWDOON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/constant illumination of yellow light stimulation/product/NEWDOON Inc
Average 90 stars, based on 1 article reviews
constant illumination of yellow light stimulation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Prizmatix ltd led stimulation light
BLA to vHip projections regulate anxiety-like behavior in morphine-withdrawn mice. (A–E) Chemogenetic experiment. (A) Workflow for the chemogenetic experiment. (B) Schematic (left) and representative image (right) of chemogenetic virus injection. Scale bar: 200 μm. (C) The Mor-A×CNO mice exhibited significantly increased central time and central distances in the OFT. (D) The Mor-A × CNO mice exhibited significantly increased open-arm times and entries in the EPM. (E) The hM4Di inhibition accelerated the decreased rate of morphine-paired preference in the Mor-A mice. (F–H) Optogenetic experiment. (F) Schematic of the virus injection site in the BLA and optical fiber implantation site in the vHip. (Right) Image of a coronal brain slice showing the expression of eNpHR-mCherry in the BLA. Scale bar: 200 μm. (G) Increased open-arm entries and time spent during the light-on epoch. (H) Increased time spent and distances traveled in the central area of the OFT during the eNpHR <t>illumination</t> epoch. The EPM (I) and OFT (J) tests of the saline + eNpHR group and the saline + mCherry group. Data are expressed as the mean ± SEM. In the chemogenetic experiment, morphine CNO-treated mice were compared with morphine DMSO-treated mice. In the CPP results, *: comparison between the extinction group and the post-test group, #: comparison between the 2 indicated groups. In the optogenetic results, #: comparison between the Mor+mcherry and the Mor+eNPHR group during the light on epoch. n = 8–10/group.* P < 0.05, ** P < 0.01, *** P < 0.001, # P < 0.05, ## P < 0.01, #### P < 0.0001.
Led Stimulation Light, supplied by Prizmatix ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/led stimulation light/product/Prizmatix ltd
Average 90 stars, based on 1 article reviews
led stimulation light - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
EKB Technologies Ltd spatial visual stimulator module dlp® light craftertm 4500 modified by ekb
BLA to vHip projections regulate anxiety-like behavior in morphine-withdrawn mice. (A–E) Chemogenetic experiment. (A) Workflow for the chemogenetic experiment. (B) Schematic (left) and representative image (right) of chemogenetic virus injection. Scale bar: 200 μm. (C) The Mor-A×CNO mice exhibited significantly increased central time and central distances in the OFT. (D) The Mor-A × CNO mice exhibited significantly increased open-arm times and entries in the EPM. (E) The hM4Di inhibition accelerated the decreased rate of morphine-paired preference in the Mor-A mice. (F–H) Optogenetic experiment. (F) Schematic of the virus injection site in the BLA and optical fiber implantation site in the vHip. (Right) Image of a coronal brain slice showing the expression of eNpHR-mCherry in the BLA. Scale bar: 200 μm. (G) Increased open-arm entries and time spent during the light-on epoch. (H) Increased time spent and distances traveled in the central area of the OFT during the eNpHR <t>illumination</t> epoch. The EPM (I) and OFT (J) tests of the saline + eNpHR group and the saline + mCherry group. Data are expressed as the mean ± SEM. In the chemogenetic experiment, morphine CNO-treated mice were compared with morphine DMSO-treated mice. In the CPP results, *: comparison between the extinction group and the post-test group, #: comparison between the 2 indicated groups. In the optogenetic results, #: comparison between the Mor+mcherry and the Mor+eNPHR group during the light on epoch. n = 8–10/group.* P < 0.05, ** P < 0.01, *** P < 0.001, # P < 0.05, ## P < 0.01, #### P < 0.0001.
Spatial Visual Stimulator Module Dlp® Light Craftertm 4500 Modified By Ekb, supplied by EKB Technologies Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spatial visual stimulator module dlp® light craftertm 4500 modified by ekb/product/EKB Technologies Ltd
Average 90 stars, based on 1 article reviews
spatial visual stimulator module dlp® light craftertm 4500 modified by ekb - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
NEWDOON Inc 473-nm light stimulation
Optogenetic activation of LHb-projecting LPO excitatory neurons produced aversion and anxiety-like behaviors in mice . (A) Experimental design to assess the effect of optogenetic activation of LHb-projecting LPO excitatory neurons on mice's behavioral performances. (B , C) Representative microphotographs showed the expression of Retro-hSyn-Cre-EGFP within LHb and AAV9-CaMKII-DIO-ChR2-mCherry in LPO. Scale bar: 100 μm and 250 μm, respectively. (D , E) Representative trajectories from the real-time place preference test. (F) Mice (n = 11) exhibited lower time in light-ON chamber (Two-way ANOVA with Sidak post-hoc test, test phase (Baseline, Real-time place test, Post) x chamber (light-ON vs. light-OFF) : F(2, 36) = 29.08, p < 0.0001; Test phase (Baseline, Real-time place test, Post) effect: F(1, 36) = 18.89, p = 0.0001; Chamber (light-ON vs. light-OFF) effect: F(2, 36) = 1.635, p = 0.2091; Ligh-OFF vs. light-ON chamber: Baseline, p = 0.9962; Real-time place test, p < 0.0001; Post: p = 0.6955). (G) Light <t>stimulation</t> had no effect on locomotor activity (Wilcoxon matched-pairs signed rank test, Baseline vs. Real-time place test: W = 27, p = 0.3757). (H) Representative trajectories from the elevated plus maze test. When optogenetically activating LHb-projecting LPO excitatory neurons (a 25-s off + 10-s on + 25-s off activation strategy), mice (n = 11) exhibited (I) decreased time (One-way ANOVA test, Treatment F(1.138, 11.38) = 12.58, p = 0.0035; OFF vs. ON: p = 0.01; ON vs. OFF, p = 0.0428), (J) decreased entry numbers in the open arms (One-way ANOVA test, Treatment F(1.604, 16.04) = 6.792, p = 0.0103; OFF vs. ON: p = 0.0317; ON vs. OFF, p = 0.4212), but no effect on (K) locomotor activity (One-way ANOVA test, Treatment F(1.778, 17.78) = 1.636, p = 0.2993; OFF vs. ON: p = 0.4521; ON vs. OFF, p = 0.2994). (L) Representative trajectories from the open field test. When the light was on, mice (n = 11) displayed (M) decreased time (One-way ANOVA test, Treatment F(1.64, 16.4) = 0.0339, p = 0.0339; OFF vs. ON: p = 0.0064; ON vs. OFF, p = 0.2238) and (N) decreased center entries in the center area (One-way ANOVA test, Treatment F(1.682, 16.82) = 22.69, p < 0.001; OFF vs. ON: p < 0.0001; ON vs. OFF, p = 0.012), but no effect on (O) locomotor activity (One-way ANOVA test, Treatment F(1.99, 19.9) = 0.01263, p = 0.9872; ON vs. OFF, p = 0.9973). *p < 0.05, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.
473 Nm Light Stimulation, supplied by NEWDOON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/473-nm light stimulation/product/NEWDOON Inc
Average 90 stars, based on 1 article reviews
473-nm light stimulation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


BLA to vHip projections regulate anxiety-like behavior in morphine-withdrawn mice. (A–E) Chemogenetic experiment. (A) Workflow for the chemogenetic experiment. (B) Schematic (left) and representative image (right) of chemogenetic virus injection. Scale bar: 200 μm. (C) The Mor-A×CNO mice exhibited significantly increased central time and central distances in the OFT. (D) The Mor-A × CNO mice exhibited significantly increased open-arm times and entries in the EPM. (E) The hM4Di inhibition accelerated the decreased rate of morphine-paired preference in the Mor-A mice. (F–H) Optogenetic experiment. (F) Schematic of the virus injection site in the BLA and optical fiber implantation site in the vHip. (Right) Image of a coronal brain slice showing the expression of eNpHR-mCherry in the BLA. Scale bar: 200 μm. (G) Increased open-arm entries and time spent during the light-on epoch. (H) Increased time spent and distances traveled in the central area of the OFT during the eNpHR illumination epoch. The EPM (I) and OFT (J) tests of the saline + eNpHR group and the saline + mCherry group. Data are expressed as the mean ± SEM. In the chemogenetic experiment, morphine CNO-treated mice were compared with morphine DMSO-treated mice. In the CPP results, *: comparison between the extinction group and the post-test group, #: comparison between the 2 indicated groups. In the optogenetic results, #: comparison between the Mor+mcherry and the Mor+eNPHR group during the light on epoch. n = 8–10/group.* P < 0.05, ** P < 0.01, *** P < 0.001, # P < 0.05, ## P < 0.01, #### P < 0.0001.

Journal: Frontiers in Cellular Neuroscience

Article Title: The Basolateral Amygdala to Ventral Hippocampus Circuit Controls Anxiety-Like Behaviors Induced by Morphine Withdrawal

doi: 10.3389/fncel.2022.894886

Figure Lengend Snippet: BLA to vHip projections regulate anxiety-like behavior in morphine-withdrawn mice. (A–E) Chemogenetic experiment. (A) Workflow for the chemogenetic experiment. (B) Schematic (left) and representative image (right) of chemogenetic virus injection. Scale bar: 200 μm. (C) The Mor-A×CNO mice exhibited significantly increased central time and central distances in the OFT. (D) The Mor-A × CNO mice exhibited significantly increased open-arm times and entries in the EPM. (E) The hM4Di inhibition accelerated the decreased rate of morphine-paired preference in the Mor-A mice. (F–H) Optogenetic experiment. (F) Schematic of the virus injection site in the BLA and optical fiber implantation site in the vHip. (Right) Image of a coronal brain slice showing the expression of eNpHR-mCherry in the BLA. Scale bar: 200 μm. (G) Increased open-arm entries and time spent during the light-on epoch. (H) Increased time spent and distances traveled in the central area of the OFT during the eNpHR illumination epoch. The EPM (I) and OFT (J) tests of the saline + eNpHR group and the saline + mCherry group. Data are expressed as the mean ± SEM. In the chemogenetic experiment, morphine CNO-treated mice were compared with morphine DMSO-treated mice. In the CPP results, *: comparison between the extinction group and the post-test group, #: comparison between the 2 indicated groups. In the optogenetic results, #: comparison between the Mor+mcherry and the Mor+eNPHR group during the light on epoch. n = 8–10/group.* P < 0.05, ** P < 0.01, *** P < 0.001, # P < 0.05, ## P < 0.01, #### P < 0.0001.

Article Snippet: For optogenetic inhibition of BLA to vHip inputs, we used a constant illumination of yellow light stimulation (5 mw, NewDoon Aurora 220).

Techniques: Virus, Injection, Inhibition, Slice Preparation, Expressing, Saline, Comparison

Optogenetic activation of LHb-projecting LPO excitatory neurons produced aversion and anxiety-like behaviors in mice . (A) Experimental design to assess the effect of optogenetic activation of LHb-projecting LPO excitatory neurons on mice's behavioral performances. (B , C) Representative microphotographs showed the expression of Retro-hSyn-Cre-EGFP within LHb and AAV9-CaMKII-DIO-ChR2-mCherry in LPO. Scale bar: 100 μm and 250 μm, respectively. (D , E) Representative trajectories from the real-time place preference test. (F) Mice (n = 11) exhibited lower time in light-ON chamber (Two-way ANOVA with Sidak post-hoc test, test phase (Baseline, Real-time place test, Post) x chamber (light-ON vs. light-OFF) : F(2, 36) = 29.08, p < 0.0001; Test phase (Baseline, Real-time place test, Post) effect: F(1, 36) = 18.89, p = 0.0001; Chamber (light-ON vs. light-OFF) effect: F(2, 36) = 1.635, p = 0.2091; Ligh-OFF vs. light-ON chamber: Baseline, p = 0.9962; Real-time place test, p < 0.0001; Post: p = 0.6955). (G) Light stimulation had no effect on locomotor activity (Wilcoxon matched-pairs signed rank test, Baseline vs. Real-time place test: W = 27, p = 0.3757). (H) Representative trajectories from the elevated plus maze test. When optogenetically activating LHb-projecting LPO excitatory neurons (a 25-s off + 10-s on + 25-s off activation strategy), mice (n = 11) exhibited (I) decreased time (One-way ANOVA test, Treatment F(1.138, 11.38) = 12.58, p = 0.0035; OFF vs. ON: p = 0.01; ON vs. OFF, p = 0.0428), (J) decreased entry numbers in the open arms (One-way ANOVA test, Treatment F(1.604, 16.04) = 6.792, p = 0.0103; OFF vs. ON: p = 0.0317; ON vs. OFF, p = 0.4212), but no effect on (K) locomotor activity (One-way ANOVA test, Treatment F(1.778, 17.78) = 1.636, p = 0.2993; OFF vs. ON: p = 0.4521; ON vs. OFF, p = 0.2994). (L) Representative trajectories from the open field test. When the light was on, mice (n = 11) displayed (M) decreased time (One-way ANOVA test, Treatment F(1.64, 16.4) = 0.0339, p = 0.0339; OFF vs. ON: p = 0.0064; ON vs. OFF, p = 0.2238) and (N) decreased center entries in the center area (One-way ANOVA test, Treatment F(1.682, 16.82) = 22.69, p < 0.001; OFF vs. ON: p < 0.0001; ON vs. OFF, p = 0.012), but no effect on (O) locomotor activity (One-way ANOVA test, Treatment F(1.99, 19.9) = 0.01263, p = 0.9872; ON vs. OFF, p = 0.9973). *p < 0.05, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Journal: Neurobiology of Stress

Article Title: Distinct populations of lateral preoptic nucleus neurons jointly contribute to depressive-like behaviors through divergent projections in male mice

doi: 10.1016/j.ynstr.2024.100667

Figure Lengend Snippet: Optogenetic activation of LHb-projecting LPO excitatory neurons produced aversion and anxiety-like behaviors in mice . (A) Experimental design to assess the effect of optogenetic activation of LHb-projecting LPO excitatory neurons on mice's behavioral performances. (B , C) Representative microphotographs showed the expression of Retro-hSyn-Cre-EGFP within LHb and AAV9-CaMKII-DIO-ChR2-mCherry in LPO. Scale bar: 100 μm and 250 μm, respectively. (D , E) Representative trajectories from the real-time place preference test. (F) Mice (n = 11) exhibited lower time in light-ON chamber (Two-way ANOVA with Sidak post-hoc test, test phase (Baseline, Real-time place test, Post) x chamber (light-ON vs. light-OFF) : F(2, 36) = 29.08, p < 0.0001; Test phase (Baseline, Real-time place test, Post) effect: F(1, 36) = 18.89, p = 0.0001; Chamber (light-ON vs. light-OFF) effect: F(2, 36) = 1.635, p = 0.2091; Ligh-OFF vs. light-ON chamber: Baseline, p = 0.9962; Real-time place test, p < 0.0001; Post: p = 0.6955). (G) Light stimulation had no effect on locomotor activity (Wilcoxon matched-pairs signed rank test, Baseline vs. Real-time place test: W = 27, p = 0.3757). (H) Representative trajectories from the elevated plus maze test. When optogenetically activating LHb-projecting LPO excitatory neurons (a 25-s off + 10-s on + 25-s off activation strategy), mice (n = 11) exhibited (I) decreased time (One-way ANOVA test, Treatment F(1.138, 11.38) = 12.58, p = 0.0035; OFF vs. ON: p = 0.01; ON vs. OFF, p = 0.0428), (J) decreased entry numbers in the open arms (One-way ANOVA test, Treatment F(1.604, 16.04) = 6.792, p = 0.0103; OFF vs. ON: p = 0.0317; ON vs. OFF, p = 0.4212), but no effect on (K) locomotor activity (One-way ANOVA test, Treatment F(1.778, 17.78) = 1.636, p = 0.2993; OFF vs. ON: p = 0.4521; ON vs. OFF, p = 0.2994). (L) Representative trajectories from the open field test. When the light was on, mice (n = 11) displayed (M) decreased time (One-way ANOVA test, Treatment F(1.64, 16.4) = 0.0339, p = 0.0339; OFF vs. ON: p = 0.0064; ON vs. OFF, p = 0.2238) and (N) decreased center entries in the center area (One-way ANOVA test, Treatment F(1.682, 16.82) = 22.69, p < 0.001; OFF vs. ON: p < 0.0001; ON vs. OFF, p = 0.012), but no effect on (O) locomotor activity (One-way ANOVA test, Treatment F(1.99, 19.9) = 0.01263, p = 0.9872; ON vs. OFF, p = 0.9973). *p < 0.05, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Article Snippet: For elevated plus maze and open field tests, mice were recorded with first 3 min as the baseline, followed by second 3 min’ delivery of 473-nm light stimulation with 10 ms, 10 Hz (Newdoon Technology) via an optic cable (200-μm core, 0.37 NA, Doric Lens).

Techniques: Activation Assay, Produced, Expressing, Activity Assay

Optogenetic activation of VTA-projecting LPO excitatory neurons produced preference and risk-taking behaviors in mice . (A) Experimental design to assess the effect of optogenetic activation of VTA-projecting LPO excitatory neurons on mice's behavioral performances. (B , C) Representative microphotographs showed the expression of Retro-hSyn-Cre-EGFP within VTA and AAV9-CaMKII-DIO-ChR2-mCherry in LPO. Scale bar: 250 μm. (D , E) Representative trajectories from the real-time place preference test. (F) Mice (n = 12) exhibited more time in light-ON chamber (Two-way ANOVA with Sidak post-hoc test, test phase (Baseline, Real-time place test, Post) x chamber (light-ON vs. light-OFF) : F(2, 33) = 36.76, p < 0.0001; test phase (Baseline, Real-time place test, Post) effect: F(1, 33) = 22.72, p < 0.0001; chamber (light-ON vs. light-OFF) effect: F(2, 23) = 0.0004, p = 0.9996; Ligh-OFF vs. light-ON chamber: Baseline, p = 0.7191; Real-time place test, p < 0.0001; Post: p = 0.9343), and (G) light stimulation had no effect on locomotor activity (Wilcoxon matched-pairs signed rank test, Baseline vs. Real-time place test: W = 30, p = 0.2661). (H) Representative trajectories from the elevated plus maze test. When optogenetically activating VTA-projecting LPO excitatory neurons (a 25-s off + 10-s on + 25-s off activation strategy), mice (n = 12) exhibited (I) increased time (nonparametric followed by Dunnett's test, p = 0.0024; OFF vs. ON: p = 0.0416; ON vs. OFF, p = 0.0024), (J) increased entry numbers in the open arms (One-way ANOVA test, Treatment F(1.441, 15.85) = 30.32, p < 0.001; OFF vs. ON: p = 0.0004; ON vs. OFF, p = 0.0002), but no effect on (K) locomotor activity (One-way ANOVA test, Treatment F(1.221, 13.43) = 0.9246, p = 0.3735; OFF vs. ON: p = 0.4205; ON vs. OFF, p = 0.3516). (L) Representative trajectories from the open field test. When the light was on, mice (n = 12) displayed (M) increased time (nonparametric followed by Dunnett's test, p = 0.0204; OFF vs. ON: p = 0.0206; ON vs. OFF, p = 0.1542), (N) increased center entries in the center area (nonparametric followed by Dunnett's test, p = 0.0001; OFF vs. ON: p = 0.0008; ON vs. OFF, p = 0.0005), but no effect on (O) locomotor activity (nonparametric followed by Dunnett's test, p = 0.9733; OFF vs. ON: p > 0.9999; ON vs. OFF, p > 0.9999). *p < 0.05, **p < 0.01, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Journal: Neurobiology of Stress

Article Title: Distinct populations of lateral preoptic nucleus neurons jointly contribute to depressive-like behaviors through divergent projections in male mice

doi: 10.1016/j.ynstr.2024.100667

Figure Lengend Snippet: Optogenetic activation of VTA-projecting LPO excitatory neurons produced preference and risk-taking behaviors in mice . (A) Experimental design to assess the effect of optogenetic activation of VTA-projecting LPO excitatory neurons on mice's behavioral performances. (B , C) Representative microphotographs showed the expression of Retro-hSyn-Cre-EGFP within VTA and AAV9-CaMKII-DIO-ChR2-mCherry in LPO. Scale bar: 250 μm. (D , E) Representative trajectories from the real-time place preference test. (F) Mice (n = 12) exhibited more time in light-ON chamber (Two-way ANOVA with Sidak post-hoc test, test phase (Baseline, Real-time place test, Post) x chamber (light-ON vs. light-OFF) : F(2, 33) = 36.76, p < 0.0001; test phase (Baseline, Real-time place test, Post) effect: F(1, 33) = 22.72, p < 0.0001; chamber (light-ON vs. light-OFF) effect: F(2, 23) = 0.0004, p = 0.9996; Ligh-OFF vs. light-ON chamber: Baseline, p = 0.7191; Real-time place test, p < 0.0001; Post: p = 0.9343), and (G) light stimulation had no effect on locomotor activity (Wilcoxon matched-pairs signed rank test, Baseline vs. Real-time place test: W = 30, p = 0.2661). (H) Representative trajectories from the elevated plus maze test. When optogenetically activating VTA-projecting LPO excitatory neurons (a 25-s off + 10-s on + 25-s off activation strategy), mice (n = 12) exhibited (I) increased time (nonparametric followed by Dunnett's test, p = 0.0024; OFF vs. ON: p = 0.0416; ON vs. OFF, p = 0.0024), (J) increased entry numbers in the open arms (One-way ANOVA test, Treatment F(1.441, 15.85) = 30.32, p < 0.001; OFF vs. ON: p = 0.0004; ON vs. OFF, p = 0.0002), but no effect on (K) locomotor activity (One-way ANOVA test, Treatment F(1.221, 13.43) = 0.9246, p = 0.3735; OFF vs. ON: p = 0.4205; ON vs. OFF, p = 0.3516). (L) Representative trajectories from the open field test. When the light was on, mice (n = 12) displayed (M) increased time (nonparametric followed by Dunnett's test, p = 0.0204; OFF vs. ON: p = 0.0206; ON vs. OFF, p = 0.1542), (N) increased center entries in the center area (nonparametric followed by Dunnett's test, p = 0.0001; OFF vs. ON: p = 0.0008; ON vs. OFF, p = 0.0005), but no effect on (O) locomotor activity (nonparametric followed by Dunnett's test, p = 0.9733; OFF vs. ON: p > 0.9999; ON vs. OFF, p > 0.9999). *p < 0.05, **p < 0.01, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Article Snippet: For elevated plus maze and open field tests, mice were recorded with first 3 min as the baseline, followed by second 3 min’ delivery of 473-nm light stimulation with 10 ms, 10 Hz (Newdoon Technology) via an optic cable (200-μm core, 0.37 NA, Doric Lens).

Techniques: Activation Assay, Produced, Expressing, Activity Assay

Optogenetic inhibition of LHb-projecting or activation of VTA-projecting LPO excitatory neurons during chronic restraint stress prevented depressive-like behaviors in mice . (A) Experimental design to assess the effect of optogenetic inhibition of LHb-projecting LPO excitatory neurons during chronic restraint stress on depressive-like behaviors in the CRS-induced depression mouse model. (B , C) Representative virus expression in the LHb and LPO. Using a 3-min off + 3-min on + 3-min off optogenetic stimulation paradigm, mice (n = 15 for control group, n = 13 for CRS group, and n = 8 for CRS + inhibition group) throughout optogenetic inhibition during chronic restraint stress displayed (D) increased time spent in open arms (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 23) = 11.22, p = 0.0002; Ctrl vs. CRS: p = 0.0011; CRS vs. CRS + inhibition, p = 0.0007) and (E) increased number of entries into open arms in the elevated plus maze test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 6.542, p = 0.004; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + inhibition, p = 0.0056), (F) increased center time (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 14.49, p < 0.001; Ctrl vs. CRS: p < 0.001; CRS vs. CRS + inhibition, p = 0.0056) but no effect on (G) number of entries in the center in the open field test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 17.98, p < 0.0001; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + inhibition, p = 0.466). And (H) increased percentage of sucrose intake in sucrose preference test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 5.825, p = 0.0068; Ctrl vs. CRS: p = 0.0297; CRS vs. CRS + inhibition, p = 0.0109) while (I) decreased immobile time in forced swim test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 4.406, p = 0.0201; Ctrl vs. CRS: p = 0.0459; CRS vs. CRS + inhibition, p = 0.039). (J) Experimental design to assess the effect of optogenetic activation of VTA-projecting LPO excitatory neurons during chronic restraint stress on depressive-like behaviors in the CRS-induced depression mouse model. (K , L) Representative virus expression in VTA and LPO. Mice (n = 15 for control group, n = 13 for CRS group, and n = 9 for CRS + activation group) after optogenetic activation during chronic restraint stress displayed (M) increased time spent in open arms (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 7.561, p = 0.0019; Ctrl vs. CRS: p = 0.0242; CRS vs. CRS + activation, p = 0.0021) and (N) increased number of entries into open arms in the elevated plus maze test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 12.07, p = 0.0001; Ctrl vs. CRS: p = 0.5592; CRS vs. CRS + activation, p = 0.0001), (O) no effect on the time in the center (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 3.343, p = 0.0473; Ctrl vs. CRS: p = 0.0385; CRS vs. CRS + activation, p = 0.313) but (P) increased number of entries in the center in the open field test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 4.52, p = 0.0182; Ctrl vs. CRS: p = 0.0453; CRS vs. CRS + activation, p = 0.0317). And (Q) increased percentage of sucrose intake in sucrose preference test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 7.217, p = 0.0024; Ctrl vs. CRS: p = 0.0023; CRS vs. CRS + activation, p = 0.0363) while (R) decreased immobile time in forced swim test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 14.01, p < 0.0001; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + activation, p = 0.0112). *p < 0.05, **p < 0.01, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Journal: Neurobiology of Stress

Article Title: Distinct populations of lateral preoptic nucleus neurons jointly contribute to depressive-like behaviors through divergent projections in male mice

doi: 10.1016/j.ynstr.2024.100667

Figure Lengend Snippet: Optogenetic inhibition of LHb-projecting or activation of VTA-projecting LPO excitatory neurons during chronic restraint stress prevented depressive-like behaviors in mice . (A) Experimental design to assess the effect of optogenetic inhibition of LHb-projecting LPO excitatory neurons during chronic restraint stress on depressive-like behaviors in the CRS-induced depression mouse model. (B , C) Representative virus expression in the LHb and LPO. Using a 3-min off + 3-min on + 3-min off optogenetic stimulation paradigm, mice (n = 15 for control group, n = 13 for CRS group, and n = 8 for CRS + inhibition group) throughout optogenetic inhibition during chronic restraint stress displayed (D) increased time spent in open arms (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 23) = 11.22, p = 0.0002; Ctrl vs. CRS: p = 0.0011; CRS vs. CRS + inhibition, p = 0.0007) and (E) increased number of entries into open arms in the elevated plus maze test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 6.542, p = 0.004; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + inhibition, p = 0.0056), (F) increased center time (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 14.49, p < 0.001; Ctrl vs. CRS: p < 0.001; CRS vs. CRS + inhibition, p = 0.0056) but no effect on (G) number of entries in the center in the open field test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 17.98, p < 0.0001; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + inhibition, p = 0.466). And (H) increased percentage of sucrose intake in sucrose preference test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 5.825, p = 0.0068; Ctrl vs. CRS: p = 0.0297; CRS vs. CRS + inhibition, p = 0.0109) while (I) decreased immobile time in forced swim test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 33) = 4.406, p = 0.0201; Ctrl vs. CRS: p = 0.0459; CRS vs. CRS + inhibition, p = 0.039). (J) Experimental design to assess the effect of optogenetic activation of VTA-projecting LPO excitatory neurons during chronic restraint stress on depressive-like behaviors in the CRS-induced depression mouse model. (K , L) Representative virus expression in VTA and LPO. Mice (n = 15 for control group, n = 13 for CRS group, and n = 9 for CRS + activation group) after optogenetic activation during chronic restraint stress displayed (M) increased time spent in open arms (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 7.561, p = 0.0019; Ctrl vs. CRS: p = 0.0242; CRS vs. CRS + activation, p = 0.0021) and (N) increased number of entries into open arms in the elevated plus maze test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 12.07, p = 0.0001; Ctrl vs. CRS: p = 0.5592; CRS vs. CRS + activation, p = 0.0001), (O) no effect on the time in the center (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 3.343, p = 0.0473; Ctrl vs. CRS: p = 0.0385; CRS vs. CRS + activation, p = 0.313) but (P) increased number of entries in the center in the open field test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 4.52, p = 0.0182; Ctrl vs. CRS: p = 0.0453; CRS vs. CRS + activation, p = 0.0317). And (Q) increased percentage of sucrose intake in sucrose preference test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 7.217, p = 0.0024; Ctrl vs. CRS: p = 0.0023; CRS vs. CRS + activation, p = 0.0363) while (R) decreased immobile time in forced swim test (One-way ANOVA test with Tukey post-hoc test, Treatment F(2, 34) = 14.01, p < 0.0001; Ctrl vs. CRS: p < 0.0001; CRS vs. CRS + activation, p = 0.0112). *p < 0.05, **p < 0.01, ***p < 0.001, N.S. not significant. Values are expressed as mean ± sem.

Article Snippet: For elevated plus maze and open field tests, mice were recorded with first 3 min as the baseline, followed by second 3 min’ delivery of 473-nm light stimulation with 10 ms, 10 Hz (Newdoon Technology) via an optic cable (200-μm core, 0.37 NA, Doric Lens).

Techniques: Inhibition, Activation Assay, Virus, Expressing, Control